Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis

BACKGROUND: Treatment options for drug-resistant tuberculosis are still limited. Linezolid has been recommended for treatment of patients with multidrug-resistant (MDR) or extensively-drug-resistant (XDR) tuberculosis, although uncertainties remain regarding its safety and tolerability in these circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Agyeman, Akosua Adom, Ofori-Asenso, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917997/
https://www.ncbi.nlm.nih.gov/pubmed/27334498
http://dx.doi.org/10.1186/s12941-016-0156-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917997/
https://www.ncbi.nlm.nih.gov/pubmed/27334498
http://dx.doi.org/10.1186/s12941-016-0156-y

Ejemplares similares